Last $42.14 USD
Change Today -0.135 / -0.32%
Volume 139.1K
ABAX On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 3:40 PM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

abaxis inc (ABAX) Key Developments

Abaxis, Inc. Announces USDA Approval of Vetscan Canine Ehrlichia Antibody Test Kit

Abaxis, Inc. announced that the Center for Veterinary Biologicals of the U.S. Department of Agriculture (USDA) has approved its VetScan Canine Ehrlichia Antibody Test Kit for use in rapid detection of canine Ehrlichia.

Abaxis, Inc. Presents at Jefferies 2014 Global Healthcare Conference, Jun-02-2014 03:00 PM

Abaxis, Inc. Presents at Jefferies 2014 Global Healthcare Conference, Jun-02-2014 03:00 PM. Venue: Grand Hyatt, New York, New York, United States. Speakers: Clinton H. Severson, Chairman, Chief Executive Officer and President.

Abaxis, Inc. Presents at 11th Annual Dental & Veterinary Conference, May-28-2014 10:50 AM

Abaxis, Inc. Presents at 11th Annual Dental & Veterinary Conference, May-28-2014 10:50 AM. Venue: The Peninsula Hotel, 700 Fifth Avenue at 55th Street, New York, New York, United States. Speakers: Clint Severson, chairman and chief executive officer.

Abaxis, Inc. and VCA Inc. Announce Long-Term Product Supply Agreement and a Co-Marketing Agreement

Abaxis, Inc. and VCA Inc. jointly announced they have entered into two long-term agreements, the first a long-term product supply agreement for VCA's Animal Hospitals and the second a co-marketing agreement with VCA's Antech Diagnostic reference laboratories. Under the long-term product supply agreement VCA will purchase VetScan VS2 chemistry analyzers and diagnostic reagent discs from Abaxis for placement in the majority of VCA's more than 600 animal hospitals located in North America. Additionally, VCA and Abaxis have entered into a non-exclusive co-marketing relationship to capitalize on new growth opportunities within the animal healthcare industry. Representatives from Abaxis and Antech Diagnostics will work together in providing complete diagnostic solutions to better serve veterinary practices throughout North America with the ability to combine Antech Diagnostic laboratory services with the use of VetScan VS2 chemistry analyzers.

Abaxis, Inc. Announces Executive Promotions

Abaxis, Inc. announced organizational changes to its leadership structure. Effective immediately, Donald Wood, chief operations officer and interim leader of North American Animal Health (NAAH), has been appointed Chief Operating Officer. Mr. Wood will continue to lead operations with an expanded leadership role over all Domestic Sales & Marketing for Abaxis, including both the Animal Health & Medical divisions. Reporting to Mr. Wood will be Craig Tockman, DVM and Rick Betts, Director of Medical Marketing.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABAX:US $42.14 USD -0.135

ABAX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Chindex International Inc $23.37 USD 0.00
Corgenix Medical Corp $0.28 USD +0.0098
Heska Corp $11.09 USD +0.28
PetMed Express Inc $14.20 USD +0.09
Trinity Biotech PLC $23.35 USD -0.09
View Industry Companies
 

Industry Analysis

ABAX

Industry Average

Valuation ABAX Industry Range
Price/Earnings 67.3x
Price/Sales 5.5x
Price/Book 4.9x
Price/Cash Flow 66.9x
TEV/Sales 4.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ABAXIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.